Human immunodeficiency virus type 1 cDNA integration: New aromatic hydroxylated inhibitors and studies of the inhibition mechanism

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2245-2253

  Farnet, C M ^a,f   Wang, B ^a   Hansen, M ^a   Lipford, J R ^b   Zalkow, L ^c   Robinson Jr , W E ^d   Siegel, J ^e   Bushman, F ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAQUINONE; COMPLEMENTARY DNA; ELLAGIC ACID; HYPERICIN; INTEGRASE; INTEGRASE INHIBITOR;

ARTICLE; DNA INTEGRATION; DRUG CROSS REACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0031660989     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2245     Document Type: Article

References (75)

1. Adachi, A., N. Ono, H. Sakai, K. Ogawa, R. Shibata, T. Kiyomasu, H. Masuike, and S. Ueda. 1991. Generation and characterization of the human immunodeficiency virus type 1 mutants. Arch. Virol. 117:45-58.
2. Billich, A., M. Schauer, S. Frank, B. Rosenwirth, and S. Billich. 1992. HIV-1 integrase: high-level production and screening assay for the endonucleolytic activity. Antivir. Chem. Chemother. 3:113-119.
3. Bowerman, B., P. O. Brown, J. M. Bishop, and H. E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478.
4. Brown, P. O. 1990. Integration of retroviral DNA. Curr. Top. Microbiol. Immunol. 157:19-48.
5. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. 1987. Correct integration of retroviral DNA in vitro. Cell 49:347-356.
6. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. 1989. Retroviral integration: structure of the initial covalent complex and its precursor, and a role for the viral IN protein. Proc. Natl. Acad. Sci. USA 86:2525-2529.
7. Bukrinsky, M. I., N. Sharova, T. L. McDonald, T. Pushkarskaya, G. W. Tarpley, and M. Stevenson. 1993. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90:6125-6129.
8. Burke, T. R., M. R. Fesen, A. Mazumder, J. Wang, A. M. Carothers, D. Grunberger, J. Driscoll, K. Kohn, and Y. Pommier. 1995. Hydroxylated aromatic inhibitors of HIV-1 integrase. J. Med. Chem. 38:4171-1178.
9. Bushman, F. D., and R. Craigie. 1991. Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA. Proc. Natl. Acad. Sci. USA 88:1339-1343.
10. Bushman, F. D., A. Engelman, I. Palmer, P. Wingfield, and R. Craigie. 1993. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. USA 90:3428-3432.
11. Bushman, F. D., T. Fujiwara, and R. Craigie. 1990. Retroviral DNA integration directed by HIV integration protein in vitro. Science 249:1555-1558.
12. Carteau, S., J. F. Mouscadet, H. Goulaouic, F. Subra, and C. Auclair. 1993. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction Biochem. Biophys. Res. Commun. 192:1409-1414.
13. Carteau, S., J. F. Mouscadet, H. Goulaouic, F. Subra, and C. Auclair. 1993. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction. Arch. Biochem. Biophys. 305:606-610.
14. Chow, S. A. 1997. In vitro assays for activities of retroviral integrase. Methods 12:306-317.
15. Chow, S. A., and P. O. Brown. 1994. Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase. J. Virol. 68:7869-7878.
16. Chow, S. A., and P. O. Brown. 1994. Substrate features important for recognition and catalysis by human immunodeficiency virus type 1 integrase identified by using novel DNA substrates. J. Virol. 68:3896-3907.
17. Chow, S. A., K. A. Vincent, V. Ellison, and P. O. Brown. 1992. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science 255:723-726.
18. Clavel, F., M. D. Hoggan, R. L. Willey, K. Strebel, M. Martin, and R. Repaske. 1989. Genetic recombination of human immunodeficiency virus. J. Virol. 63:1455-1459.
19. Coffin, J. M. 1996. Retroviridae: the viruses and their replication, p. 1767-1848. In B. N. Fields, D. M. Knipe, and R. M. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
20. Cohen, P. A., J. B. Hudson, and G. H. Towers. 1996. Antiviral activities of anthraquinones, bianthrones and hypericin derivatives from lichens. Experientia 52:180-183.
21. Craigie, R., T. Fujiwara, and F. Bushman. 1990. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 62:829-837.
22. Cushman, M., W. M. Golegiewski, Y. Pommier, A. Mazumder, D. Reymen, E. De Clercq, L. Graham, and W. G. Rice. 1995. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase. J. Med. Chem. 38:443-452.
23. Cushman, M., and P. Sherman. 1992. Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. Biochem. Biophys. Res. Commun. 185:85-90.
24. Drake, R. R., N. Neamati, H. Hong, A. A. Pilon, P. Sunthanker, S. D. Hume, G. W. Milne, and Y. Pommier. 1998. Identification of a nucleotide binding site in HIV-1 integrase. Proc. Natl. Acad. Sci. USA 95:4170-4175.
25. Eich, E., H. Pertz, M. Kaloga, J. Schulz, M. R. Fesen, A. Mazumder, and Y. Pommier. 1996. (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J. Med. Chem. 39:89-95.
26. Ellison, V. H., H. Abrams, T. Roe, J. Lifson, and P. O. Brown. 1990. Human immunodeficiency virus integration in a cell-free system. J. Virol. 64:2711-2715.
27. Farnet, C., and F. D. Bushman. 1997. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88:1-20.
28. Farnet, C., R. Lipford, B. Wang, and F. D. Bushman. 1996. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc. Natl. Acad. Sci. USA 93:9742-9747.
29. Farnet, C. M., and F. D. Bushman. 1996. HIV cDNA integration: molecular biology and inhibitor development. AIDS 10(Suppl. A):3-11.
30. Farnet, C. M., and W. A. Haseltine. 1990. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl. Acad. Sci. USA 87:4164-4168.
31. Farnet, C. M., and W. A. Haseltine. 1991. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1910-1915.
32. Fehr, M. J., S. L. Carpenter, and J. W. Petrich. 1994. The role of oxygen in the photoinduced antiviral activity of hypericin. Bioorg. Med. Chem. Lett. 4:1339-1344.
33. Fesen, M. R., K. W. Kohn, F. Leteurtre, and Y. Pommier. 1993. Inhibitors of human immunodeficiency virus integrase. Proc. Natl. Acad. Sci. USA 90: 2399-2403.
34. Fesen, M. R., Y. Pommier, F. Leteurtre, S. Hiroguchi, J. Yung, and K. W. Kohn. 1994. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol. 48:595-608.
35. Fujiwara, T., and K. Mizuuchi. 1988. Retroviral DNA integration: structure of an integration intermediate. Cell 54:497-504.
36. Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 17:569-576.
37. Goff, S., P. Traktman, and D. Baltimore. 1981. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:239-248.
38. Goff, S. P. 1992. Genetics of retroviral integration. Annu. Rev. Genet. 26: 527-544.
39. Hansen, M., and F. D. Bushman. 1997. HIV-2 preintegration complexes, activities in vitro and response to inhibitors. J. Virol. 71:3351-3356.
40. Hazuda, D. J., P. J. Felock, J. C. Hastings, B. Pramanik, and A. L. Wolfe. 1997. Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. J. Virol. 71:7005-7011.
41. Higuchi, H., K. Mori, A. Kato, T. Ohkuma, T. Endo, H. Kaji, and A. Kaji. 1991. Antiretroviral activities of anthraquinones and their inhibitory effects on reverse transcriptase. Antivir. Res. 15:205-216.
42. Hong, H., N. Neamati, S. Wang, M. C. Nicklaus, A. Mazumder, H. Zhao, T. R. Burke, Y. Pommier, and G. W. A. Milne. 1997. Discovery of HIV-1 integrase inhibitors by pharmacophore searching. J. Med. Chem. 40:930-936.
43. Hudson, J. B., I. Lopez-Bazzocchi, and G. H. Towers. 1991. Antiviral activities of hypericin. Antivir. Res. 15:101-112.
44. Hwang, Y., B. Wang, and F. D. Bushman. 1998. Molluscum contagiosum virus topoisomerase: purification, activities, and response to inhibitors. J. Virol. 72:3401-3406.
45. Jamison, G., and F. D. Bushman. Unpublished data.
46. Jenkins, T. M., A. B. Hickman, F. Dyda, R. Ghirlando, D. R. Davies, and R. Craigie. 1995. Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of Hydrophobic residues. Proc. Natl. Acad. Sci. USA 92:6057-6061.
47. Katz, R. A., G. Merkel, J. Kulkosky, J. Leis, and A. M. Skalka. 1990. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 63:87-95.
48. Katzman, M., R. A. Katz, A. M. Skalka, and J. Leis. 1989. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J. Virol. 63:5319-5327.
49. LaFemina, R. L., P. L. Graham, K. LeGrow, J. C. Hastings, A. Wolfe, S. D. Young, E. A. Emini, and D. J. Hazuda. 1995. Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrob. Agents Chemother. 39:320-324.
50. Lenard, J., A. Rabson, and R. Vanderoef. 1993. Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc. Natl. Acad. Sci. USA 90:158-162.
51. Lipford, J. R., S. T. Worland, and C. M. Farnet. 1994. Nucleotide binding by the HIV-1 integrase protein in vitro. J. Acquired Immune Defic. Syndr. 7:1215-1223.
52. Mazumder, A., D. Cooney, R. Agbaria, M. Gupta, and Y. Pommier. 1994. Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido-3′-deoxythymidylate. Proc. Natl. Acad. Sci. USA 91:5771-5775.
53. Mazumder, A., A. Gazit, A. Levitzki, M. Nicklaus, J. Yung, G. Kohlhagen, and Y. Pommier. 1995. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase. Biochemistry 34:15111-15122.
54. Mazumder, A., M. Gupta, D. M. Perrin, D. S. Sigman, M. Rabinovitz, and Y. Pommier. 1995. Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex. AIDS Res. Hum. Retroviruses 11:115-125.
55. Mazumder, A., N. Neamati, J.-P. Sommadossi, G. Gosselin, R. F. Schinazi, J.-L. Imbach, and Y. Pommier. 1996. Effects of nucleotide analogs on human immunodeficiency virus type-1 integrase. Mol. Pharmacol. 49:621-628.
56. Mazumder, A., K. Raghavan, J. Weinstein, K. W. Kohn, and Y. Pommier. 1995. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem. Pharmacol. 49:1165-1170.
57. Meruelo, D., G. Lavie, and D. Lavie. 1988. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA 85:5230-5234.
58. Miller, M. D., C. M. Farnet, and F. D. Bushman. 1997. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71:5382-5390.
59. Mizuuchi, K. 1992. Polynucleotidyl transfer reactions in transpositional DNA recombination. J. Biol. Chem. 287:21273-21276.
60. Mouscadet, J. F., S. Carteau, H. Goulaouic, F. Subra, and C. Auclair. 1994. Triplex-mediated inhibition of HIV DNA integration in vitro. J. Biol. Chem. 269:21635-21638.
61. Mouscadet, J. F., C. Ketterle, H. Goulaouic, S. Carteau, F. Subra, M. Le Bret, and C. Auclair. 1994. Triple helix formation with short oligonucleotide-intercalator conjugates matching the HIV-1 U3 LTR end sequence. Biochemistry 33:4187-4196.
62. Neamati, N., H. Hong, A. Mazumder, S. Wang, S. Sunder, M. C. Nicklaus, G. W. A. Milne, B. Proksa, and Y. Pommier. 1997. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J. Med. Chem. 40:942-951.
63. Nicklaus, M. C., N. Neamati, H. Hong, A. Mazumder, S. Sunder, J. Chen, G. W. A. Milne, and Y. Pommier. 1997. HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching. J. Med. Chem. 40:920-929.
64. Plasterk, R. H. A. 1995. The HIV integrase catalytic core. Struct. Biol. 2:87-90.
65. Robinson, W. E., M. Cordeiro, S. Abdel-Malek, Q. Jia, S. A. Chow, M. G. Reinecke, and W. M. Mitchell. 1996. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol. Pharmacol. 50: 846-855.
66. Robinson, W. E., M. G. Reinecke, S. Abdel-Malek, Q. Jia, and S. A. Chow. 1996. Inhibitors of HIV-1 replication that inhibit HIV integrase. Proc. Natl. Acad. Sci. USA 93:6326-6331.
67. Robinson, W. E., Jr. Unpublished data.
68. Sakai, H., M. Kawamura, J.-I. Sakuragi, S. Sakuragi, R. Shibata, A. Ishimoto, N. Ono, S. Ueda, and A. Adachi. 1993. Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J. Virol. 67:1169-1174.
69. Schinazi, R. F., C. K. Chu, J. R. Babu, B. J. Oswald, V. Saalmann, D. L. Cannon, B. F. H. Eriksson, and M. Nasr. 1990. Anthraquinones as a new class of antiviral agents against human immunodeficiency virus. Antivir. Res. 13:265-272.
70. Sherman, P. A., and J. A. Fyfe. 1990. Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. Proc. Natl. Acad. Sci. USA 87:5119-5123.
71. Stanwell, C., B. Ye, S. H. Yuspa, and T. R. Burke. 1996. Cell protein cross-linking by erbstatin and related compounds. Biochem. Pharmacol. 52: 475-480.
72. Stevenson, M., S. Haggerty, C. A. Lamonica, C. M. Meier, S.-K. Welch, and A. J. Wasiak. 1990. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J. Virol. 64:2421-2425.
73. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
74. Zembower, D. E., C.-M. Kam, J. C. Powers, and L. H. Zalkow. 1992. Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin. J. Med. Chem. 35:1597-1605.
75. Zhao, H., N. Neamati, H. Hong, A. Mazumder, S. Wang, S. Sunder, G. W. A. Milne, Y. Pommier, and T. R. Burke. 1997. Coumarin-based inhibitors of HIV integrase. J. Med. Chem. 40:242-249.